Actively Recruiting

Phase 3
Age: 18Years - 75Years
All Genders
NCT07165951

Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

Led by Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. · Updated on 2025-12-24

566

Participants Needed

70

Research Sites

156 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study adopts a randomized, open label, placebo-controlled, multicenter trial design. OS was the primary endpoint, and eligible subjects were randomly divided into 1:1 groups and received TQB2868 injection and anlotinib hydrochloride capsules combined with chemotherapy, compared to placebo combined with chemotherapy.

CONDITIONS

Official Title

Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Subjects voluntarily agree to participate and sign informed consent
  • Age between 18 and 75 years old inclusive
  • Diagnosis of pancreatic ductal adenocarcinoma confirmed by tissue or cytology
  • Stage IV metastatic pancreatic cancer according to AJCC 8th Edition TNM system
  • No prior systemic anti-tumor or investigational drug treatment; if prior neoadjuvant/adjuvant therapy, at least 6 months since last administration and toxicity recovered to acceptable levels
  • At least one measurable lesion per RECIST v1.1 criteria
  • ECOG performance status score of 0 to 1
  • Expected survival longer than 12 weeks
  • Laboratory tests meet protocol standards
  • Women of childbearing potential must use effective contraception during study and for 6 months after, with negative serum pregnancy test within 7 days prior to enrollment
  • Men must agree to use effective contraception during study and for 6 months after
Not Eligible

You will not qualify if you...

  • History or current other malignant tumors within 5 years prior to first medication
  • Conditions affecting intravenous injection, venous blood collection, or oral medication intake
  • Unresolved adverse reactions from previous treatments above certain severity levels, except certain specified toxicities
  • Major surgery, significant trauma, or long-term untreated wounds/fractures within 4 weeks before first medication
  • Severe bleeding events within 4 weeks prior to first administration
  • Arterial or venous thrombotic events within 6 months before first administration
  • Hepatitis B or unstable hepatitis C infection requiring antiviral treatment during study
  • Active syphilis infection requiring treatment
  • History of active pulmonary infections or symptomatic pneumonia
  • History of psychotropic drug abuse or mental disorders preventing participation
  • Previous allogeneic bone marrow or solid organ transplantation
  • Severe or uncontrolled illnesses
  • Need for immunosuppressive therapy or certain hormone treatments within 7 days before first dose
  • Tumor-related symptoms difficult to control
  • Known allergy to components of study drugs
  • Participation in other anti-tumor clinical trials within 4 weeks prior to first medication
  • Pregnancy or breastfeeding
  • Other serious conditions judged by researchers to threaten safety or study completion

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 70 locations

1

The First Affiliated Hospital of USTC Anhui Provincial Hospital

Hefei, Anhui, China, 230001

Not Yet Recruiting

2

Anhui Provincial Cancer Hospital

Hefei, Anhui, China, 230031

Not Yet Recruiting

3

Peking University First Hospital

Beijing, Beijing Municipality, China, 100034

Not Yet Recruiting

4

Beijing Friendship Hospital,Capital Medical University

Beijing, Beijing Municipality, China, 100050

Not Yet Recruiting

5

The Fifth Medical Center of Chinese People's Liberation Army General Hospital

Beijing, Beijing Municipality, China, 100071

Not Yet Recruiting

6

Beijing Daxing District People'S Hospital

Beijing, Beijing Municipality, China, 102699

Not Yet Recruiting

7

The First Affiliated Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, China, 400010

Not Yet Recruiting

8

Mengchao Hepatobiliary Hospital OF Fujian Medical University

Fuzhou, Fujian, China, 350001

Not Yet Recruiting

9

The Firstaffiliated Hospital of Xiamen University

Xiamen, Fujian, China, 361001

Not Yet Recruiting

10

Zhongshan Hospital Xiamen University

Xiamen, Fujian, China, 361001

Not Yet Recruiting

11

Gansu Provincial Hospital

Lanzhou, Gansu, China, 730000

Not Yet Recruiting

12

The First Hospital of Lanzhou University

Lanzhou, Gansu, China, 730000

Not Yet Recruiting

13

Lanzhou University Second Hospital

Lanzhou, Gansu, China, 730030

Not Yet Recruiting

14

Sun Yat-Sen University

Guangzhou, Guangdong, China, 510000

Not Yet Recruiting

15

The First Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong, China, 510030

Not Yet Recruiting

16

Sun Yat-Sen University Cancer Center

Guangzhou, Guangdong, China, 510062

Not Yet Recruiting

17

Longhua District Central Hospital

Shenzhen, Guangdong, China, 518000

Not Yet Recruiting

18

Guangxi Cancer Institute

Nanning, Guangxi, China, 530000

Not Yet Recruiting

19

Guizhou Medical University Affiliated Cancer Hospital Co., LTD

Guiyang, Guizhou, China, 550001

Not Yet Recruiting

20

Affiliated Hospital of Zunyi Medical Universityl

Zunyi, Guizhou, China, 563000

Not Yet Recruiting

21

Hainan general hospital

Haikou, Hainan, China, 570311

Not Yet Recruiting

22

Cancer Hospital Chinese Academy pf Medical Sciences

Langfang, Hebei, China, 065000

Not Yet Recruiting

23

Tangshan peopel's Hospital

Tangshan, Hebei, China, 063001

Not Yet Recruiting

24

Daqing Oilfield General Hospital

Daqing, Heilongjiang, China, 163001

Not Yet Recruiting

25

Harbin Medical University Cancer Hospital

Haerbin, Heilongjiang, China, 150000

Not Yet Recruiting

26

The First Affiliated Hospital of Henan University of Science & Technology

Luoyang, Henan, China, 471000

Not Yet Recruiting

27

Henan Cancer Hospital

Zhengzhou, Henan, China, 450000

Not Yet Recruiting

28

The First Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, China, 450000

Not Yet Recruiting

29

Zhongnan Hospital of Wuhan University

Wuhan, Hubei, China, 430000

Not Yet Recruiting

30

Hubei Cancer Hospital

Wuhan, Hubei, China, 430079

Not Yet Recruiting

31

Xiangyang Central Hospital

Xiangyang, Hubei, China, 441021

Not Yet Recruiting

32

Hunan Cancer Hospital

Changsha, Hunan, China, 410000

Not Yet Recruiting

33

People's Hospital of Hunan Province

Changsha, Hunan, China, 410005

Not Yet Recruiting

34

Xiangya Hospital of Central South University

Changsha, Hunan, China, 410008

Actively Recruiting

35

Peking University Cancer Hospital Inner Mongolia Hospital

Hohhot, Inner Mongolia, China, 10000

Not Yet Recruiting

36

Jiangyin People'S Hospital

Jiangyin, Jiangsu, China, 214431

Not Yet Recruiting

37

Nanjing Drum Tower Hospital

Nanjing, Jiangsu, China, 210000

Not Yet Recruiting

38

Jiangsu Province Hospital

Nanjing, Jiangsu, China, 210029

Not Yet Recruiting

39

Nantong Tumor Hospital

Nantong, Jiangsu, China, 226361

Not Yet Recruiting

40

The First Affiliated Hospital of Soochow University

Suzhou, Jiangsu, China, 215006

Not Yet Recruiting

41

The Affiliated Hospital of Xuzhou Medical University

Xuzhou, Jiangsu, China, 221004

Not Yet Recruiting

42

The First Affiliated Hospital of Nanchang University

Nanchang, Jiangxi, China, 330006

Not Yet Recruiting

43

Jilin Cancer Hospital

Changchun, Jilin, China, 130000

Not Yet Recruiting

44

The first hospital of Jilin University

Changchun, Jilin, China, 130000

Not Yet Recruiting

45

Liaoning Cancer Hospital

Shenyang, Liaoning, China, 110000

Not Yet Recruiting

46

The First Hospital of China Medical University

Shenyang, Liaoning, China, 110801

Not Yet Recruiting

47

The Second Affiliated Hospital of PLA Air Force Military Medical University

Xi'an, Shaanxi, China, 710038

Not Yet Recruiting

48

The First Affiliated Hospital of Xi 'An Jiaotong University

Xi'an, Shaanxi, China, 710061

Not Yet Recruiting

49

Qilu Hospital of Shandong University

Jinan, Shandong, China, 250012

Not Yet Recruiting

50

Linyi people's hospital

Linyi, Shandong, China, 276000

Not Yet Recruiting

51

Linyi Cancer Hospital

Liyi, Shandong, China, 276034

Not Yet Recruiting

52

The Affiliated Hospital Of Medical College Qingdao University

Qingdao, Shandong, China, 266000

Not Yet Recruiting

53

Zhongshan Hospital

Shanghai, Shanghai Municipality, China, 200030

Not Yet Recruiting

54

Fudan University Shanghai Cancer Center

Shanghai, Shanghai Municipality, China, 200032

Actively Recruiting

55

Shanghai Sixth People's Hospital

Shanghai, Shanghai Municipality, China, 200233

Not Yet Recruiting

56

Shanghai General Hospital

Shanghai, Shanghai Municipality, China, 201620

Not Yet Recruiting

57

Shanxi Cancer Hospital

Taiyuan, Shanxi, China, 030000

Not Yet Recruiting

58

First Hospital of Shanxi Medical University

Taiyuan, Shanxi, China, 030045

Not Yet Recruiting

59

Sichuan Cancer Hospital

Chengdu, Sichuan, China, 610041

Not Yet Recruiting

60

The Affiliated Hospital of Southwest Medical University

Luzhou, Sichuan, China, 646000

Not Yet Recruiting

61

Affiliated Hospital of North Sichuan Medical College

Nanchong, Sichuan, China, 637000

Not Yet Recruiting

62

Tianjin Cancer Hospital Airport Hospital

Tianjin, Tianjin Municipality, China, 300300

Not Yet Recruiting

63

Tianjin Medical University Cancer Institute & Hospital

Tianjin, Tianjin Municipality, China, 300300

Not Yet Recruiting

64

People's Hospital of Xinjiang Uygur Autonomous Region

Ürümqi, Xinjiang, China, 830000

Not Yet Recruiting

65

Yunnan Cancer Hospital

Kunming, Yunnan, China, 650118

Not Yet Recruiting

66

The Second Affiliated Hospital Zhejiang University School of Medicine

Hangzhou, Zhejiang, China, 310009

Not Yet Recruiting

67

Sir Run Run Shaw Hospital , affiliated with the Zhejiang University School of Medicine

Hangzhou, Zhejiang, China, 311000

Not Yet Recruiting

68

Ningbo Medical Center Lihuili Hospital

Ningbo, Zhejiang, China, 315100

Not Yet Recruiting

69

Shaoxing People's Hospital

Shaoxing, Zhejiang, China, 312000

Not Yet Recruiting

70

Wenzhou Medical University Affiliated First Hospital

Wenzhou, Zhejiang, China, 325000

Not Yet Recruiting

Loading map...

Research Team

X

Xianjun Yu, Doctor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) | DecenTrialz